Albany Molecular Research, Inc.
AMRI
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $607.34 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.65 |
| Beta | 1.04 |
| Outstanding Shares | 42,452,000 |
Return
| Return on Equity | -18.85% |
|---|---|
| Return on Assets | -4.81% |
| Return on Invested Capital | -2.68% |
Valuation & Multiples
| P/E Ratio | -13.15 |
|---|---|
| PEG | 25.38 |
| Price to Sales | 1.36 |
| Price to Book Ratio | 3.11 |
| Enterprise Value to Revenue | 0.89 |
| Enterprise Value to EBIT | -34.82 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 1.07 |
| Debt to Equity | 2.05 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%0% |
|---|---|
| Total Invested | $22 |
| Investors Holding | 10% |
ESG Score
No data